Is DGLRX or JNJ a better dividend investment in 2026?

DGLRX currently yields 29.97% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: DGLRX offers higher current income.

What is the dividend yield difference between DGLRX and JNJ?

DGLRX has a forward dividend yield of 29.97% ($4.77/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 26.61 percentage points.

Home › Compare › DGLRX vs JNJ

DGLRX vs JNJ: Dividend Comparison 2026

DGLRX yields 29.97% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 DGLRX wins by $112.1K in total portfolio value

INVESTMENT

TIME HORIZON10 years

DGLRX

● Live price

29.97%

Share price

$15.92

Annual div

$4.77

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$132.2K

Annual income

$17,472.41

Full DGLRX calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — DGLRX vs JNJ

📍 DGLRX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	DGLRX	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, DGLRX + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

DGLRX pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DGLRX

Annual income on $10K today (after 15% tax)

$2,547.60/yr

After 10yr DRIP, annual income (after tax)

$14,851.55/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, DGLRX beats the other by $14,147.94/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DGLRX + JNJ for your $10,000?

DGLRX: 50%JNJ: 50%

100% JNJ50/50100% DGLRX

Portfolio after 10yr

$76.1K

Annual income

$9,150.10/yr

Blended yield

12.03%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

DGLRX

No analyst data

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DGLRX buys

JNJ buys

No recent congressional trades found for DGLRX or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricDGLRXJNJ

Forward yield	29.97% ✓	3.36%
Annual dividend / share	$4.77	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$132.2K ✓	$20.0K
Annual income after 10y	$17,472.41 ✓	$827.78
Total dividends collected	$90.2K ✓	$5.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: DGLRX vs JNJ ($10,000, DRIP)

Year	DGLRX Portfolio	DGLRX Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$13,697	$2,997.17	$10,676	$355.77	+$3.0K → DGLRX
2	$18,493	$3,836.71	$11,407	$389.39	+$7.1K → DGLRX
3	$24,628	$4,841.10	$12,198	$426.53	+$12.4K → DGLRX
4	$32,378	$6,025.52	$13,056	$467.62	+$19.3K → DGLRX
5	$42,047	$7,403.27	$13,987	$513.12	+$28.1K → DGLRX
6	$53,976	$8,985.31	$14,998	$563.56	+$39.0K → DGLRX
7	$68,534	$10,779.81	$16,098	$619.52	+$52.4K → DGLRX
8	$86,124	$12,791.84	$17,295	$681.69	+$68.8K → DGLRX
9	$107,175	$15,023.23	$18,599	$750.82	+$88.6K → DGLRX
10	$132,150	$17,472.41	$20,022	$827.78	+$112.1K → DGLRX

DGLRX vs JNJ: Complete Analysis 2026

DGLRX — Stock

The investment seeks long-term total return. To pursue its goal, the fund normally invests at least 80% of its net assets, plus any borrowings for investment purposes, in stocks. The fund's investments will be focused on companies located in the developed markets. Examples of "developed markets" are the United States, Canada, Japan, Australia, Hong Kong and Western Europe. It may invest in the securities of companies of any market capitalization. The fund's sub-adviser, Walter Scott & Partners Limited (Walter Scott), seeks investment opportunities in companies with fundamental strengths that indicate the potential for sustainable growth.

Full DGLRX Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this DGLRX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DGLRX vs SCHD DGLRX vs JEPI DGLRX vs O DGLRX vs KO DGLRX vs MAIN DGLRX vs ABBV DGLRX vs MRK DGLRX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.